02-Apr-15 Pfizer Inc said it will cease vaccines sales in China after an import licence for the only vaccine it sold there was not renewed. Drug makers face growing difficulties obtaining approvals in the world’s no. 2 drug market, where pharmaceutical executives say regulators have added more red tape to the process of bringing drugs to market. [image: Fortune]

02-Apr-15 More private high-end hospitals have come to Shenzhen as its middle-class keeps expanding. The city is also reported to be encouraging private investment in the public health sector. “The city government has... included the hospital into the national health care insurance network to help patients reduce their costs,” said Liu Jiangning, executive president of C-Mer (Shenzhen) Dennis Law Eye Hospital. [image: Shenzhen Standard]

02-Apr-15 China has completed the constitution of its much-anticipated new regulations for online drug retailing. Once the provisions on deregulation of prescription drugs and loosening of distribution conditions are implemented, a 'golden age' for medical e-commerce companies is expected to begin. The medical e-commerce sector has been valued at RMB7 bn (USD1.1 bn) in 2014. [image: Xinhua Finance]

31-Mar-15 Alibaba's healthcare subsidiary will tie up with Zhejiang DiAn Diagnostics to develop an online hospital platform. Ali Health is looking to technology to help overhaul China's fragmented and over-burdened healthcare system. [image: Greetlane News]

31-Mar-15 China will almost double the number of its general doctors by 2020, trim its public sector and improve technology, as it seeks to reform a healthcare system plagued by overloading and poor rural services, its main administrative authority has said. [image: Fox News]